{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:12:17Z","timestamp":1790205137744,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-04064-9","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:58:15Z","timestamp":1779299895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stage-dependent reorganization of amyloid PET region\u2013symptom bipartite networks in drug-na\u00efve, amyloid-positive Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Youngsoon","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4195-8971","authenticated-orcid":false,"given":"Yong Tae","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"4064_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","volume":"7","author":"CG Lyketsos","year":"2011","unstructured":"Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, et al. Neuropsychiatric symptoms in Alzheimer\u2019s disease: neurobiology and treatment. Alzheimers Dement. 2011;7:532\u20139.","journal-title":"Alzheimers Dement"},{"key":"4064_CR2","doi-asserted-by":"publisher","first-page":"e0211953","DOI":"10.1371\/journal.pone.0211953","volume":"14","author":"M Panca","year":"2019","unstructured":"Panca M, Livingston G, Barber J, Cooper C, La Frenais F, Marston L, et al. Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England\u2014the MARQUE study. PLoS One. 2019;14:e0211953.","journal-title":"PLoS One"},{"key":"4064_CR3","doi-asserted-by":"publisher","first-page":"h369","DOI":"10.1136\/bmj.h369","volume":"350","author":"HC Kales","year":"2015","unstructured":"Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350:h369.","journal-title":"BMJ"},{"key":"4064_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jagp.2019.03.023","volume":"28","author":"MH Burhanullah","year":"2020","unstructured":"Burhanullah MH, Tschanz JT, Peters ME, Leoutsakos JM, Matyi J, Lyketsos CG, et al. Neuropsychiatric symptoms as risk factors for cognitive decline in clinically normal older adults: The Cache County Study. Am J Geriatr Psychiatry. 2020;28:64\u201371.","journal-title":"Am J Geriatr Psychiatry"},{"key":"4064_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jalz.2015.05.017","volume":"12","author":"Z Ismail","year":"2016","unstructured":"Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement. 2016;12:195\u2013202.","journal-title":"Alzheimers Dement"},{"key":"4064_CR6","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1001\/archpsyc.65.10.1193","volume":"65","author":"YE Geda","year":"2008","unstructured":"Geda YE, Roberts RO, Knopman DS, Petersen RC, Christianson TJH, Pankratz VS, et al. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive ageing: population-based study. Arch Gen Psychiatry. 2008;65:1193\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"4064_CR7","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/brain\/awn151","volume":"131","author":"PD Bruen","year":"2008","unstructured":"Bruen PD, McGeown WJ, Shanks MF, Venneri A. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer\u2019s disease. Brain. 2008;131:2455\u201363.","journal-title":"Brain"},{"key":"4064_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306\u201319.","journal-title":"Ann Neurol"},{"key":"4064_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"4064_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","volume":"67","author":"MA Mintun","year":"2006","unstructured":"Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology. 2006;67:446\u201352.","journal-title":"Neurology"},{"key":"4064_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2967\/jnumed.109.069088","volume":"51","author":"DF Wong","year":"2010","unstructured":"Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med. 2010;51:913\u201320.","journal-title":"J Nucl Med"},{"key":"4064_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3988\/jcn.2020.16.1.131","volume":"16","author":"I Lee","year":"2020","unstructured":"Lee I, Na HR, Byun BH, Lim JH, Kang MJ, Kim SY, et al. Clinical usefulness of 18F-FC119S positron-emission tomography as an auxiliary diagnostic method for dementia: an open-label, single-dose, evaluator-blind clinical trial. J Clin Neurol. 2020;16:131\u20139.","journal-title":"J Clin Neurol"},{"key":"4064_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3988\/jcn.2022.0207","volume":"19","author":"K Baik","year":"2023","unstructured":"Baik K, Jeon S, Park M, Lee YG, Lee PH, Sohn YH, et al. Comparison between 18F-Florapronol and 18F-Florbetaben imaging in patients with cognitive impairment. J Clin Neurol. 2023;19:260\u20139.","journal-title":"J Clin Neurol"},{"key":"4064_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000111082","volume":"25","author":"P Aalten","year":"2008","unstructured":"Aalten P, Verhey FRJ, Boziki M, Brugnolo A, Bullock R, Byrne EJ, et al. Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II. Dement Geriatr Cogn Disord. 2008;25:1\u20138.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"4064_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mam.2015.05.005","volume":"43\u201344","author":"PB Rosenberg","year":"2015","unstructured":"Rosenberg PB, Nowrangi MA, Lyketsos CG. Neuropsychiatric symptoms in Alzheimer\u2019s disease: what might be associated brain circuits?. Mol Asp Med. 2015;43\u201344:25\u201337.","journal-title":"Mol Asp Med"},{"key":"4064_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nn.4502","volume":"20","author":"DS Bassett","year":"2017","unstructured":"Bassett DS, Sporns O. Network neuroscience. Nat Neurosci. 2017;20:353\u201364.","journal-title":"Nat Neurosci"},{"key":"4064_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.conb.2012.11.015","volume":"23","author":"O Sporns","year":"2013","unstructured":"Sporns O. Network attributes for segregation and integration in the human brain. Curr Opin Neurobiol. 2013;23:162\u201371.","journal-title":"Curr Opin Neurobiol"},{"key":"4064_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1440.011","volume":"1124","author":"RL Buckner","year":"2008","unstructured":"Buckner RL, Andrews-Hanna JR, Schacter DL. The brain\u2019s default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci. 2008;1124:1\u201338.","journal-title":"Ann N Y Acad Sci"},{"key":"4064_CR19","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1523\/JNEUROSCI.5587-06.2007","volume":"27","author":"WW Seeley","year":"2007","unstructured":"Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. 2007;27:2349\u201356.","journal-title":"J Neurosci"},{"key":"4064_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.12779\/dnd.2012.11.3.87","volume":"11","author":"YT Kwak","year":"2012","unstructured":"Kwak YT, Yang Y, Kwak SG. Clinical characteristics of behavioral and psychological symptoms in patients with drug-na\u00efve Alzheimer\u2019s disease. Dement Neurocogn Disord. 2012;11:87\u201394.","journal-title":"Dement Neurocogn Disord"},{"key":"4064_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2009.03.024","volume":"62","author":"WW Seeley","year":"2009","unstructured":"Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative diseases target large-scale human brain networks. Neuron. 2009;62:42\u201352.","journal-title":"Neuron"},{"key":"4064_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/bies.201500004","volume":"37","author":"MA Busche","year":"2015","unstructured":"Busche MA, Konnerth A. Neuronal hyperactivity\u2014a key defect in Alzheimer\u2019s disease?. Bioessays. 2015;37:624\u201332.","journal-title":"Bioessays"},{"key":"4064_CR23","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1073\/pnas.1206171109","volume":"109","author":"MA Busche","year":"2012","unstructured":"Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, et al. Critical role of soluble amyloid-\u03b2 for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2012;109:8740\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4064_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrn.2016.141","volume":"17","author":"JJ Palop","year":"2016","unstructured":"Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci. 2016;17:777\u201392.","journal-title":"Nat Rev Neurosci"},{"key":"4064_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01150-x","volume":"8","author":"S Palmqvist","year":"2017","unstructured":"Palmqvist S, Sch\u00f6ll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, et al. Earliest accumulation of \u03b2-amyloid occurs within the default mode network and concurrently affects brain connectivity. Nat Commun. 2017;8:1214.","journal-title":"Nat Commun"},{"key":"4064_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nrn2575","volume":"10","author":"E Bullmore","year":"2009","unstructured":"Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci. 2009;10:186\u201398.","journal-title":"Nat Rev Neurosci"},{"key":"4064_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the NIA\u2013AA workgroups on diagnostic guidelines. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"4064_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2967\/jnumed.122.264414","volume":"64","author":"SK Kang","year":"2023","unstructured":"Kang SK, Kim D, Shin SA, Kim YK, Choi H, Lee JS. Fast and accurate amyloid brain PET quantification without MRI using deep neural networks. J Nucl Med. 2023;64:659\u201366.","journal-title":"J Nucl Med"},{"key":"4064_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13195-023-01279-6","volume":"15","author":"GJ Goodwin","year":"2023","unstructured":"Goodwin GJ, Moeller S, Nguyen A, Arora A, O\u2019Connor ML, Rheaume K, et al. Network analysis of neuropsychiatric symptoms in Alzheimer\u2019s disease. Alzheimers Res Ther. 2023;15:135.","journal-title":"Alzheimers Res Ther"},{"key":"4064_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/00031305.1982.10482778","volume":"36","author":"CH Wagner","year":"1982","unstructured":"Wagner CH. Simpson\u2019s paradox in real life. Am Stat. 1982;36:46\u20138.","journal-title":"Am Stat"},{"key":"4064_CR31","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/archneur.61.11.1731","volume":"61","author":"KL Lanct\u00f4t","year":"2004","unstructured":"Lanct\u00f4t KL, Herrmann N, Nadkarni NK, Leibovitch FS, Caldwell CB, Black SE, et al. Medial temporal hypoperfusion and aggression in Alzheimer disease. Arch Neurol. 2004;61:1731\u20137.","journal-title":"Arch Neurol"},{"issue":"Suppl 5","key":"4064_CR32","first-page":"S95","volume":"9","author":"PT Trzepacz","year":"2013","unstructured":"Trzepacz PT, Yu P, Bhamidipati PK, Willis BA, Forrester TD, Tabas LB, et al. Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer\u2019s disease. Alzheimers Dement. 2013;9(Suppl 5):S95\u2013104. e1.","journal-title":"Alzheimers Dement"},{"key":"4064_CR33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.psychres.2017.12.063","volume":"261","author":"PR Padala","year":"2018","unstructured":"Padala PR, Padala KP, Lensing SY, Dennis RA, Bopp MM, Parkes CM, et al. Repetitive transcranial magnetic stimulation for apathy in mild cognitive impairment: a double-blind, randomized, sham-controlled, cross-over pilot study. Psychiatry Res. 2018;261:312\u20138.","journal-title":"Psychiatry Res"},{"key":"4064_CR34","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3233\/JAD-200640","volume":"77","author":"PR Padala","year":"2020","unstructured":"Padala PR, Boozer EM, Lensing SY, Parkes CM, Hunter CR, Dennis RA, et al. Neuromodulation for apathy in Alzheimer\u2019s disease: a double-blind, randomized, sham-controlled pilot study. J Alzheimers Dis. 2020;77:1483\u201393.","journal-title":"J Alzheimers Dis"},{"key":"4064_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3988\/jcn.2016.12.1.57","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee J, Choi BH, Oh E, Sohn EH, Lee AY. Treatment of Alzheimer\u2019s disease with repetitive transcranial magnetic stimulation combined with cognitive training: a prospective, randomized, double-blind, placebo-controlled study. J Clin Neurol. 2016;12:57\u201364.","journal-title":"J Clin Neurol"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04064-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04064-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04064-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:52:38Z","timestamp":1783403558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04064-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4064"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04064-9","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations and with the principles of the Declaration of Helsinki. This study was approved by the Institutional Review Board of Soonchunhyang University College of Medicine, Cheonan Hospital (IRB number: 2025-03-011). Written informed consent was obtained from all participants or their caregivers after providing a complete description of the study. This study does not contain any identifiable images or personal information requiring consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"342"}}